EUVIMEDEUVIMED entdecken
Crossref

Clinical usefulness of metagenomic next-generation sequencing for Talaromyces marneffei diagnosis in China: a retrospective study

Xuan Zhang, Xinfei Yao, Huixin Chen, Meifang Yang, Dongsheng Han

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04856-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Xuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Inn…. Hauptthemen laut MEDLINE: Talaromyces, High-Throughput Nucleotide Sequencing, Mycoses, Metagenomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Key R&D Program of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Metagenomic next-generation sequencing (mNGS) has been widely used in the diagnosis of infectious diseases. However, studies on Talaromyces marneffei detection using mNGS remain scarce. Therefore, this study aimed to explore the diagnostic performance of mNGS in T. marneffei. METHODS: Between March 2021 and June 2023, patients who were discharged with a final diagnosis of talaromycosis, or confirmed T. marneffei infection by mNGS, culture or pathological examination were included in the study. Culture and mNGS were performed simultaneously for all patients. Clinical data were retrieved for analysis. RESULTS: A total of 78 patients were enrolled, with 40 in the talaromycosis group and 38 in the suspected-talaromycosis group. In the talaromycosis group, mNGS showed a higher positivity rate(40/40, 100.0%) compared to culture(34/40, 85.0%)(P = 0.111). All patients in the suspected-talaromycosis group tested negative via culture, while mNGS yielded positive results. The T. marneffei reads in the talaromycosis group were significantly higher than in the suspected-talaromycosis group (4399 vs. 28, P < 0.001). In the suspected-talaromycosis group, of the four patients with low reads who did not receive antifungal therapy, one died and one lung lesion progressed; most patients(31/34, 91.2%) recovered after receiving appropriate antifungal therapy. CONCLUSION: mNGS proves to be a rapid and highly sensitive method for detecting T. marneffei. Higher reads of T. marneffei correspond to a higher likelihood of infection. However, cases with low reads necessitate a comprehensive approach, integrating clinical manifestations, laboratory tests, and imaging examinations to confirm T. marneffei infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalaromycesHigh-Throughput Nucleotide SequencingMycosesMetagenomicsHumansChinaMaleRetrospective StudiesFemaleMiddle AgedAdultAgedSensitivity and Specificity

Stichwörter der Autor:innen

DiagnosisMetagenomic next-generation sequencingTalaromyces marneffeiTalaromycosis

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
  • Department of Laboratory Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. hands@zju.edu.cn.
  • Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou, Zhejiang, China. hands@zju.edu.cn.
  • Institute of Laboratory Medicine, Zhejiang University, Hangzhou, Zhejiang, China. hands@zju.edu.cn.

Förderung

  • National Key R&D Program of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhang, X., Yao, X., Chen, H., Yang, M., & Han, D. (2024). Clinical usefulness of metagenomic next-generation sequencing for Talaromyces marneffei diagnosis in China: a retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04856-1

Vancouver

Zhang X, Yao X, Chen H, Yang M, Han D. Clinical usefulness of metagenomic next-generation sequencing for Talaromyces marneffei diagnosis in China: a retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04856-1

BibTeX
@article{Zhang2024,
  author = {Zhang, Xuan and Yao, Xinfei and Chen, Huixin and Yang, Meifang and Han, Dongsheng},
  title = {Clinical usefulness of metagenomic next-generation sequencing for Talaromyces marneffei diagnosis in China: a retrospective study},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04856-1}
}
Kostenlos starten →